title: Editorial: vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum? Authors' reply.
authors.affiliation: Center for Colitis and Crohn's Disease, University of California San Francisco, San Francisco, CA, USA.
authors.forename: U
authors.initials: U
authors.lastname: Mahadevan
authors.affiliation: University Hospital Gasthuisberg, Leuven, Belgium.
authors.forename: S
authors.initials: S
authors.lastname: Vermeire
authors.affiliation: Takeda Pharmaceuticals USA, Inc., Deerfield, IL, USA.
authors.forename: K
authors.initials: K
authors.lastname: Lasch
authors.affiliation: Takeda Development Centre Europe Ltd, London, UK.
authors.forename: B
authors.initials: B
authors.lastname: Abhyankar
authors.affiliation: Takeda Development Centre Europe Ltd, London, UK.
authors.forename: F
authors.initials: F
authors.lastname: Bhayat
authors.affiliation: Takeda Development Centre Europe Ltd, London, UK.
authors.forename: A
authors.initials: A
authors.lastname: Blake
authors.affiliation: Department of Pediatrics, Susan and Leonard Feinstein IBD Clinical Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
authors.forename: M
authors.initials: M
authors.lastname: Dubinsky
mesh_terms: D061067:Antibodies, Monoclonal, Humanized; D003093:Colitis, Ulcerative; D005260:Female; D006801:Humans; D011247:Pregnancy
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C543529:vedolizumab